Catalyst Wire Dossier Catalyst Wire Dossier

Rilonacept (Arcalyst)

rilonacept · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rilonacept (Arcalyst), covering 2015-12-11 to 2017-04-28. Get the full timeline:

Most recent: Clinical Trial Update: Study Utilizing Rilonacept in Gout Exacerbations [Phase 3]

See pricing